Omega 3, 6, 9
Natural health product licensed in Canada
- Other names
- Five Elements
- Licence holder
- Global Cosmeceuticals Corp.
- NPN or DIN-HM
- 80117471
- Status
- Active licence
- Licence date
- 28 March 2022
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 20 mg AT | Not calculated |
| Borago officinalis Source : Borago officinalis - Graine Potency : 40 mg alpha-Linolenic acid | 400 mg | Not calculated |
| Borago officinalis Source : Borago officinalis - Graine Potency : 130 mg Linoleic acid | Not specified | Not calculated |
| Borago officinalis Source : Borago officinalis - Graine Potency : 80 mg gamma-linolenic acid | Not specified | Not calculated |
| Linum usitatissimum Source : Linum usitatissimum - Graine Potency : 200 mg alpha-Linolenic acid | 450 mg | Not calculated |
| Linum usitatissimum Source : Linum usitatissimum - Graine Potency : 120 mg Oleic acid | Not specified | Not calculated |
| Linum usitatissimum Source : Linum usitatissimum - Graine Potency : 100 mg Linoleic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 105 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 105 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 75 mg Docosahexaenoic acid | 200 mg | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 75 mg Docosahexaenoic acid | 200 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 5 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Source of alpha-linolenic acid (ALA) for the maintenance of good health. Source of essential fatty acids for the maintenance of good health. Source of linoleic acid (LA) for the maintenance of good health. Source of omega-6 fatty acids for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80117471
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.